arrow
Y

Yuichiro Suzuki

university of yamanashi
H指数:16
被引数:7,211

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metabolic Burden and Hyperuricemia Are Associated With CKD-Related Outcomes in Individuals With and Without Steatotic Liver Disease

代谢负担和高尿酸血症与有无脂肪性肝病的个体中与CKD相关结局相关

2026-09-070
PRE
Risk Factors for the Exacerbation of Esophageal Varices in Patients Receiving Atezolizumab plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma

不可切除性肝细胞癌患者接受阿替利珠单抗联合贝伐珠单抗治疗时食管静脉曲张恶化的危险因素

2025-09-010
PRE
Real-world trends in the use and outcomes of novel androgen receptor signaling inhibitor therapy in patients with non-metastatic castration-resistant prostate cancer: a multicenter retrospective study

非转移性去势抵抗性前列腺癌患者中新型雄激素受体信号抑制剂疗法的使用和结局的实际情况:一项多中心回顾性研究

2025-07-080
PRE
Evaluation of weight loss and improvement of steatotic liver disease using magnetic resonance imaging in patients with metabolic dysfunction associated steatotic liver disease

磁共振成像评价代谢功能障碍相关脂肪性肝病患者体重减轻和脂肪性肝病改善情况

2025-01-210
OA
New Surgical Criteria for Intraductal Papillary Mucinous Neoplasm Based on the Age-Adjusted Charlson Comorbidity Index Values and Presence of Solid Component
2024-11-171
OAAI
A Simple Clinical Scoring System to Determine the Risk of Pancreatic Cancer in the General Population
2024-03-200
OAAI
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large-scale multicenter retrospective study

日本2018年2014年普通人群中非酒精性脂肪性肝病的患病率及相关代谢因素: 一项大规模多中心回顾性研究

2023-08-2812
PRE
Effect of a combination of pemafibrate and a mild low-carbohydrate diet on obese and non-obese patients with metabolic-associated fatty liver disease
2023-03-056
OAAI
Significance of serum IP-10/CXCL10 measurement in predicting post-direct acting antiviral treatment liver function in patients with HCV-decompensated liver cirrhosis
2022-12-134
PRE
Analysis of direct-acting antiviral-resistant hepatitis C virus haplotype diversity by single-molecule and long-read sequencing
2022-03-315
OAAI